Skip to content
drillr.ai

MMSI

Merit Medical Systems, Inc.

NASDAQ · USHealthcareMedical - Instruments & Supplies
$75.17+1.59%

Price as of Jul 20, 2026

MMSI news

Merit Medical Systems, Inc. news

A server-rendered, paginated timeline of the latest available company news.

  1. Merit Medical Shareholders Elect Scott R. Ward to Board of Directors

    SOUTH JORDAN, Utah, May 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that shareholders elected Scott R. Ward to the company’s Board of Directors at Merit’s annual meeting of shareholders. Mr. Ward was elected to serve a three-year term. “On behalf of the Board, we are pleased with Scott Ward’s election to Merit’s Board of Directors,” said F. Ann Millner, Merit’s Chair of the Board.

    Globe Newswire ·

  2. Merit Medical to Participate in the Bank of America Healthcare Conference

    SOUTH JORDAN, Utah, May 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, today announced that Merit management will participate in the Bank of America 2026 Health Care Conference, to be held in Las Vegas, Nevada, May 12-14, 2026. The management team will participate in a fireside chat session on Tuesday, May 12th at 3:00 pm Pacific Time / 6:00 pm Eastern Time. A live audio webcast of the fireside chat

    Globe Newswire ·

  3. Merit Medical Reports First Quarter 2026 Results and Updates Full-Year Guidance

    Financial Highlights† * Reported revenue of $381.9 million, up 7% * Constant currency revenue* and constant currency revenue, organic* up 5% and up 3%, respectively * Constant currency revenue, organic* increased 4%, excluding revenue from divested product line * GAAP operating margin of 11.6%, compared to 11.5% in prior year period * Non-GAAP operating margin* of 19.7%, compared to 19.3% in prior year period * GAAP EPS $0.68, up 39% * Non-GAAP EPS* $0.94, up 9% * Free cash flow* generation of

    Globe Newswire ·

  4. Merit Medical Systems to Announce First Quarter 2026 Results on April 30, 2026

    SOUTH JORDAN, Utah, April 02, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today that it will release its financial results for the quarter ended March 31, 2026, after the close of the stock market on Thursday, April 30, 2026. Merit plans to hold its investor conference call on the same day (Thursday, April 30, 2026) at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific). To access the confer

    Globe Newswire ·

  5. Merit Medical Acquires View Point Medical, Inc., expanding the Merit Therapeutic Oncology Portfolio

    SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark(®) Detection Imaging System and OneMark Tissue Markers. The aggregate transaction consideration, including the assumption of ViewPoint

    Globe Newswire ·

  6. Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain

    Medtronic and Merit Medical Systems enter into agreement to offer new, FDA-cleared ViaVerte™ system, a basivertebral nerve ablation treatment for chronic vertebrogenic lower-back pain PR Newswire GALWAY, Ireland, March 24, 2026 Exclusive agreement expands Medtronic's comprehensive pain interventions portfolio, increases treatment options for patients living with chronic pain GALWAY, Ireland, March 24, 2026 /PRNewswire/ -- Medtronic plc, a global leader in healthcare technology, today announced t

    PR Newswire ·

  7. Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent

    SOUTH JORDAN, Utah, March 16, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced the US commercial release of the Resilience Through-the-Scope (TTS) Esophageal Stent. The Resilience stent is the newest product in Merit’s Endoscopy portfolio, joining a comprehensive offering of treatment options for patients with disease in the esophagus. The new stent is indicated for treatment of esophageal fistulas and strictures (narr

    Globe Newswire ·